| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
|
J Clin Oncol
|
2005
|
8.56
|
|
2
|
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
|
Int J Radiat Oncol Biol Phys
|
2006
|
3.40
|
|
3
|
High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study.
|
Int J Radiat Oncol Biol Phys
|
2005
|
3.32
|
|
4
|
Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.
|
J Natl Compr Canc Netw
|
2013
|
3.03
|
|
5
|
Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study.
|
J Clin Oncol
|
2013
|
2.91
|
|
6
|
Adoption of intensity-modulated radiation therapy for breast cancer in the United States.
|
J Natl Cancer Inst
|
2011
|
2.77
|
|
7
|
Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
|
Int J Radiat Oncol Biol Phys
|
2003
|
2.41
|
|
8
|
Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.
|
Arch Ophthalmol
|
2005
|
2.05
|
|
9
|
Esophageal and esophagogastric junction cancers.
|
J Natl Compr Canc Netw
|
2011
|
2.03
|
|
10
|
Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.90
|
|
11
|
Out-of-pocket health-care expenditures among older Americans with cancer.
|
Value Health
|
2004
|
1.86
|
|
12
|
Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.
|
J Natl Cancer Inst
|
2011
|
1.69
|
|
13
|
Effect of radiation therapy on permanent pacemaker and implantable cardioverter-defibrillator function.
|
Heart Rhythm
|
2012
|
1.68
|
|
14
|
Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.67
|
|
15
|
Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.64
|
|
16
|
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.59
|
|
17
|
A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.
|
J Clin Oncol
|
2007
|
1.55
|
|
18
|
Esophageal and esophagogastric junction cancers, version 1.2015.
|
J Natl Compr Canc Netw
|
2015
|
1.52
|
|
19
|
The application of lean thinking to the care of patients with bone and brain metastasis with radiation therapy.
|
J Oncol Pract
|
2007
|
1.48
|
|
20
|
CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.38
|
|
21
|
Gastric cancer.
|
J Natl Compr Canc Netw
|
2010
|
1.35
|
|
22
|
Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer.
|
J Clin Oncol
|
2013
|
1.30
|
|
23
|
Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.28
|
|
24
|
Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer.
|
Cancer
|
2012
|
1.18
|
|
25
|
Features predicting sentinel lymph node positivity in Merkel cell carcinoma.
|
J Clin Oncol
|
2011
|
1.16
|
|
26
|
Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
|
Radiother Oncol
|
2005
|
1.08
|
|
27
|
Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer.
|
J Clin Oncol
|
2002
|
1.06
|
|
28
|
Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.05
|
|
29
|
Short-term and long-term reproducibility of lung tumor position using active breathing control (ABC).
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.05
|
|
30
|
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.05
|
|
31
|
The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
|
Lung Cancer
|
2007
|
1.03
|
|
32
|
High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.03
|
|
33
|
Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.01
|
|
34
|
Gastric Cancer Clinical Practice Guidelines.
|
J Natl Compr Canc Netw
|
2006
|
1.00
|
|
35
|
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.
|
J Natl Compr Canc Netw
|
2016
|
0.99
|
|
36
|
Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS Report No. 25.
|
Arch Ophthalmol
|
2005
|
0.97
|
|
37
|
Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors.
|
J Neurooncol
|
2002
|
0.94
|
|
38
|
Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
|
Arch Ophthalmol
|
2006
|
0.93
|
|
39
|
Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.93
|
|
40
|
Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located.
|
Radiother Oncol
|
2007
|
0.93
|
|
41
|
Esophageal cancer.
|
J Natl Compr Canc Netw
|
2008
|
0.93
|
|
42
|
Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.92
|
|
43
|
Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer.
|
Lung Cancer
|
2004
|
0.92
|
|
44
|
Esophageal cancer. Clinical practice guidelines in oncology.
|
J Natl Compr Canc Netw
|
2003
|
0.92
|
|
45
|
Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients.
|
J Clin Oncol
|
2002
|
0.92
|
|
46
|
A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.91
|
|
47
|
Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma.
|
Cancer
|
2003
|
0.91
|
|
48
|
Delivering High-Quality Cancer Care: The Critical Role of Quality Measurement.
|
Healthc (Amst)
|
2014
|
0.90
|
|
49
|
Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung cancer: potential indication for radiotherapy planning.
|
J Thorac Oncol
|
2011
|
0.90
|
|
50
|
Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.90
|
|
51
|
Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.89
|
|
52
|
Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experience.
|
Breast J
|
2007
|
0.89
|
|
53
|
Accelerated partial breast irradiation: what is dosimetric effect of advanced technology approaches?
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.87
|
|
54
|
Esophageal Cancer Clinical Practice Guidelines.
|
J Natl Compr Canc Netw
|
2006
|
0.87
|
|
55
|
The need for physician leadership in creating a culture of safety.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.87
|
|
56
|
Gastric cancer. Clinical practice guidelines in oncology.
|
J Natl Compr Canc Netw
|
2003
|
0.86
|
|
57
|
Evaluation of the influence of breathing on the movement and modeling of lung tumors.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.86
|
|
58
|
Physiological imaging-defined, response-driven subvolumes of a tumor.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.86
|
|
59
|
Time to treatment in patients with stage III non-small cell lung cancer.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.85
|
|
60
|
Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer.
|
Clin Cancer Res
|
2007
|
0.85
|
|
61
|
Genetic variations in TGFβ1, tPA, and ACE and radiation-induced thoracic toxicities in patients with non-small-cell lung cancer.
|
J Thorac Oncol
|
2013
|
0.85
|
|
62
|
Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy.
|
Urology
|
2003
|
0.84
|
|
63
|
Development and validation of disease-specific measures for choroidal melanoma: COMS-QOLS report No. 2.
|
Arch Ophthalmol
|
2003
|
0.83
|
|
64
|
Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort.
|
Dermatol Surg
|
2013
|
0.83
|
|
65
|
Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.
|
Urology
|
2004
|
0.82
|
|
66
|
Ophthalmic artery occlusion secondary to radiation-induced vasculopathy.
|
J Neuroophthalmol
|
2004
|
0.82
|
|
67
|
Treatment recommendations for locally advanced, non-small-cell lung cancer: the influence of physician and patient factors.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.81
|
|
68
|
A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrences.
|
Breast J
|
2004
|
0.81
|
|
69
|
Investigation of the diffusion abnormality index as a new imaging biomarker for early assessment of brain tumor response to radiation therapy.
|
Neuro Oncol
|
2013
|
0.78
|
|
70
|
NCCN Guidelines implementation in the multidisciplinary Merkel Cell Carcinoma Program at the University of Michigan.
|
J Natl Compr Canc Netw
|
2014
|
0.78
|
|
71
|
Modern approaches to localized cancer of the esophagus.
|
J Natl Compr Canc Netw
|
2011
|
0.78
|
|
72
|
The role of radiation therapy in thoracic tumors.
|
Hematol Oncol Clin North Am
|
2006
|
0.78
|
|
73
|
Revisiting fetal dose during radiation therapy: evaluating treatment techniques and a custom shield.
|
J Appl Clin Med Phys
|
2016
|
0.77
|
|
74
|
Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer.
|
Invest New Drugs
|
2012
|
0.77
|
|
75
|
Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board: (part 2 of 2 part series).
|
Cancer Imaging
|
2013
|
0.75
|
|
76
|
Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board (part 1 of 2 part series).
|
Cancer Imaging
|
2013
|
0.75
|
|
77
|
Dosimetric review of cardiac implantable electronic device patients receiving radiotherapy.
|
J Appl Clin Med Phys
|
2015
|
0.75
|
|
78
|
Treatment of Keloids With Excision and Adjuvant Radiation: A Single Center Experience and Review of the Literature.
|
Ann Plast Surg
|
2016
|
0.75
|
|
79
|
The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminoma.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.75
|
|
80
|
Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.75
|
|
81
|
Recent advances in radiation oncology.
|
J Neuroophthalmol
|
2004
|
0.75
|
|
82
|
Designing targets for elective nodal irradiation in lung cancer radiotherapy: a planning study.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.75
|